Abstracts

Search by keyword or author name.

Showing 851 abstracts.

Immune Correlates of Herpes Zoster in HIV-Infected Children and Youth.
Magnitude and persistence of humoral, mucosal and cell-mediated immunity (CMI) after administering quadrivalent human papillomavirus vaccine (QHPV) to HIV+ children and cross-reactivity with nonvaccine serotypes.

Study

P1047
Inflammatory and Coagulation Biomarker Trajectories from Late Pregnancy to Six Weeks Postpartum in HIV-infected Women who Continue versus Discontinue Antiretroviral Therapy after Delivery.
Strong influence of CYP2B6 Genotypic Polymorphisms (Geno) on Efavirenz (EFV) Pharmacokinetics (PK) in HIV-infected (HIV+) Children <3 years of Age: Implications for an EFV Dosing Approach in Young Children.

Study

P1070
Low Darunavir (DRV) and Etravirine (ETR) Exposure When Used in Combination in HIV-Infected Children and Adolescents.

Study

P1058A
Predictors of Virologic and Clinical Response to Nevirapine (NVP) vs Lopinvavir/Ritonavir (LPV/r)-Based Antiretroviral Therapy (ART) in Infants and Children With and Without Prior NVP Exposure for the Prevention of Mother-to-Child HIV Transmission (PMTCT).

Study

P1060
Factors Associated with Lack of Viral Suppression at Delivery in the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) P1025.

Study

P1025
Emergence of nevirapine (NVP) resistance in HIV-infected infants exposed to NVP for prevention of mother-to-child transmission and treatment of maternal HIV infection: HIV Prevention Trials Network 046 study.
Age-Related Differences in Plasma and Intracellular (IC) Tenofovir (TFV) Concentrations.
Immunological Recovery in HIV-Infected Children: Differences by Baseline CD4% and Age.